BRIM Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	283.63	798.43	502.76	948	837.99	399.75
Short-Term Investments	784.08	360	1,346	747.63	-	23.84
Cash & Short-Term Investments	1,068	1,158	1,849	1,696	837.99	423.59
Cash Growth	-40.44%	-37.34%	9.03%	102.34%	97.83%	149.98%
Accounts Receivable	0.65	0.63	-	-	-	-
Other Receivables	43	41.82	23.36	6.24	0.45	0.37
Receivables	43.66	42.46	23.36	6.24	0.45	0.37
Inventory	0.58	0.67	-	-	-	-
Prepaid Expenses	10.81	6.99	4.07	11.1	10.55	6.65
Other Current Assets	0.7	0.14	0	-	-	-
Total Current Assets	1,123	1,209	1,876	1,713	848.99	430.61
Property, Plant & Equipment	13.45	14.51	11.79	6.37	7.99	3.62
Long-Term Investments	19.59	23.55	38.27	57.3	82.33	60.35
Goodwill	67.56	67.56	-	-	-	-
Other Intangible Assets	502.75	512.06	483.39	1.34	0.09	-
Other Long-Term Assets	1.36	1.37	1.02	0.7	0.59	0.86
Total Assets	1,728	1,828	2,411	1,779	939.99	495.44
Accounts Payable	0.95	0.85	-	-	-	-
Accrued Expenses	25.56	47.36	15.52	36.04	16.99	12.34
Current Portion of Long-Term Debt	2.67	2.97	-	-	-	-
Current Portion of Leases	4.65	5.84	4.23	3.48	3.63	2.85
Current Unearned Revenue	2.12	0.83	-	-	-	-
Other Current Liabilities	5.15	9.09	331.08	2.52	1.87	2.05
Total Current Liabilities	41.11	66.94	350.84	42.05	22.48	17.23
Long-Term Debt	5.97	6.46	-	-	-	-
Long-Term Leases	0.03	0.68	3.54	0.11	2.81	0.32
Total Liabilities	47.11	74.08	354.38	42.16	25.3	17.55
Common Stock	1,330	1,332	1,315	1,158	932.54	692.54
Additional Paid-In Capital	1,137	1,364	1,636	1,725	589.72	454.31
Retained Earnings	-1,086	-1,021	-884.69	-1,149	-771.19	-746.92
Comprehensive Income & Other	212.7	-20.38	-9.85	2.95	163.63	77.96
Total Common Equity	1,593	1,655	2,056	1,737	914.69	477.89
Minority Interest	87.96	98.64	-	-	-	-
Shareholders' Equity	1,681	1,754	2,056	1,737	914.69	477.89
Total Liabilities & Equity	1,728	1,828	2,411	1,779	939.99	495.44
Total Debt	13.32	15.96	7.78	3.59	6.44	3.16
Net Cash (Debt)	1,054	1,142	1,841	1,692	831.55	420.42
Net Cash Growth	-40.97%	-37.94%	8.80%	103.48%	97.79%	157.57%
Net Cash Per Share	8.03	8.69	15.78	16.83	11.66	7.09
Filing Date Shares Outstanding	133.02	133.21	131.5	115.75	93.25	69.25
Total Common Shares Outstanding	133.02	133.21	131.5	115.75	93.25	69.25
Working Capital	1,082	1,142	1,525	1,671	826.51	413.38
Book Value Per Share	11.98	12.42	15.64	15.00	9.81	6.90
Tangible Book Value	1,023	1,075	1,573	1,735	914.6	477.89
Tangible Book Value Per Share	7.69	8.07	11.96	14.99	9.81	6.90
Machinery	17.56	15.99	9.12	6.46	4.84	3.59
Leasehold Improvements	3.78	3.67	3.67	3.44	3.19	3.07